PCOS Renamed PMOS to Reflect Its Systemic Health Impact
Polycystic Ovary Syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to highlight its broader systemic impact beyond the ovaries. A global consensus involving 56 medical and patient-advocacy groups and a 10-year survey of 22,000 experts—with findings published in Lancet and other journals—drives the change. The condition affects about one in eight women and is a leading cause of infertility, with symptoms spanning irregular/heavy periods, facial hair, acne, weight gain, mood swings, and ovarian cysts, underscoring PMOS as a multi‑organ disorder rooted in insulin resistance.
